Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
regulatory fda clinical-trials

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug

Newsdesk profile image
by Newsdesk
Updated
FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug Krystal Biotech has suspended a study of a skin cancer therapy called KB707, citing a shift in the approach toward drug approvals by the regulatory agency. Fierce Biotech: Krystal Dis... [2219 chars]

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More